Share Issue/Capital Change • Jan 22, 2024
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 3613A
Kelso Group Holdings PLC
22 January 2024
22 January 2024
Kelso Group Holdings Plc ("Kelso" or the "Company")
Admission of Placing Shares
Further to the announcement published on 16 January 2024, Kelso, the main market listed acquisition vehicle, has made an application to admit a total of 62,594,999 new ordinary shares ("Placing Shares") to the Official List of the FCA and to the Main Market (Standard List) of the London Stock Exchange ("LSE"). It is expected that settlement for the Placing Shares and Admission will become effective at 8:00 a.m. on 23 January 2024, and that dealings in the Placing Shares will commence at that time.
Following Admission, the total number of Ordinary Shares and voting rights in the Company will be 375,569,999. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
For further information please contact:
| Kelso Group Holdings plc | +44 (0) 75 4033 3933 |
| John Goold, Chief Executive Officer Mark Kirkland, Chief Financial Officer Jamie Brooke, Chief Investment Officer |
|
| Zeus (Broker) | +44 (0) 20 3829 5000 |
| Nick Cowles, Ed Beddows (Investment Banking) Ben Robertson (Corporate Broking) |
About Kelso
Kelso was established in 2022 to identify, engage and unlock trapped value in the UK stock market. Kelso's strategy is to invest in situations where there is an anomaly between the intrinsic value and prospects of a company and its stock market valuation. Kelso will, in particular, look for situations where it believes the sum of the parts of a business is greater than the current value.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
STRGPUQAGUPCGMB
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.